Influence of hepatic fibrosis and inflammation: Correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging - Fig 3
- N. Verloh (6694034)
- U. Probst (6694037)
- K. Utpatel (6694040)
- F Zeman (6694043)
- F. Brennfleck (6694046)
- J. M. Werner (6694049)
- C. Fellner (6694052)
- C. Stroszczynski (6694055)
- M. Evert (6694058)
- P. Wiggermann (6694061)
- M. Haimerl (6694064)
Publication date
May 2019
DOI Publisher
Public Library of Science (PLoS)Abstract
Representative images of a case with (A) high hepatic enhancement (RE: 1.29), absent inflammation (mHAI 0) and no fibrotic marker (ISHAK 0) is shown in comparison to a case with (B) low hepatic enhancement (RE: 0.30) paired with active inflammation (mHAI 9) and fibrosis (ISHAK 4). The first column represents the non-contrasted MR image while the second column represents the hepatobiliary phase. The corresponding histopathological imaging of the evaluated hepatic sections is shown in the third column. All displayed MR images have the same window and center level. The scale bar on histopathological images represents 500 μm.</p
Add to ORKG